Analyst Ratings For NASDAQ:FLGT – Fulgent Genetics (NASDAQ:FLGT)
Today, Credit Suisse Group lowered its price target on NASDAQ:FLGT – Fulgent Genetics (NASDAQ:FLGT) to per share.
Some recent analyst ratings include
- 3/1/2018-Piper Jaffray was Downgraded by analysts at Piper Jaffray from a “Overweight ➝ Neutral” rating to a “” rating.
- 11/7/2017-Raymond James was Downgraded by analysts at Raymond James from a “Outperform ➝ Mkt Perform” rating to a “” rating.
- 10/24/2016-BTIG Research initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:FLGT – Fulgent Genetics (NASDAQ:FLGT)
NASDAQ:FLGT – Fulgent Genetics (NASDAQ:FLGT) has insider ownership of 58.80% and institutional ownership of 7.92%.
- On 3/8/2018 Paul Kim, CFO, sold 1,628 with an average share price of $3.76 per share and the total transaction amounting to $6,121.28.
- On 11/30/2017 Ming Hsieh, Insider, bought 2,000 with an average share price of $3.60 per share and the total transaction amounting to $7,200.00.
- On 11/20/2017 Ming Hsieh, CEO, bought 7,259 with an average share price of $3.28 per share and the total transaction amounting to $23,809.52.
- On 11/16/2017 Ming Hsieh, Insider, bought 2,205 with an average share price of $3.23 per share and the total transaction amounting to $7,122.15.
- On 11/14/2017 Ming Hsieh, Insider, bought 10,504 with an average share price of $3.30 per share and the total transaction amounting to $34,663.20.
- On 11/13/2017 Paul Kim, CFO, sold 1,573 with an average share price of $3.22 per share and the total transaction amounting to $5,065.06.
- On 11/9/2017 Ming Hsieh, CEO, bought 11,520 with an average share price of $3.47 per share and the total transaction amounting to $39,974.40.
Recent Trading Activity for NASDAQ:FLGT – Fulgent Genetics (NASDAQ:FLGT)
Shares of NASDAQ:FLGT – Fulgent Genetics closed the previous trading session at 3.95 up +0.07 1.80% with shares trading hands.